BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 14732626)

  • 1. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
    Razmy A; Lang AE; Shapiro CM
    Arch Neurol; 2004 Jan; 61(1):97-102. PubMed ID: 14732626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.
    Paus S; Brecht HM; Köster J; Seeger G; Klockgether T; Wüllner U
    Mov Disord; 2003 Jun; 18(6):659-67. PubMed ID: 12784269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.
    Dewey RB; Reimold SC; O'Suilleabhain PE
    Arch Neurol; 2007 Mar; 64(3):377-80. PubMed ID: 17353380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease.
    Dusek P; Busková J; Růzicka E; Majerová V; Srp A; Jech R; Roth J; Sonka K
    Clin Neuropharmacol; 2010 Jul; 33(4):186-90. PubMed ID: 20661025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.
    Linazasoro G;
    J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleepiness in Parkinson's disease: a controlled study.
    Brodsky MA; Godbold J; Roth T; Olanow CW
    Mov Disord; 2003 Jun; 18(6):668-72. PubMed ID: 12784270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive daytime sleepiness in parkinsonism.
    Arnulf I
    Sleep Med Rev; 2005 Jun; 9(3):185-200. PubMed ID: 15893249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
    Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daytime sleep latency in medication-matched Parkinsonian patients with and without sudden onset of sleep.
    Möller JC; Rethfeldt M; Körner Y; Stiasny-Kolster K; Cassel W; Meindorfner C; Rissling I; Krüger HP; Oertel WH
    Mov Disord; 2005 Dec; 20(12):1620-2. PubMed ID: 16078226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study.
    Möller JC; Stiasny K; Hargutt V; Cassel W; Tietze H; Peter JH; Krüger HP; Oertel WH
    Mov Disord; 2002 May; 17(3):474-81. PubMed ID: 12112193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group.
    Hobson DE; Lang AE; Martin WR; Razmy A; Rivest J; Fleming J
    JAMA; 2002 Jan 23-30; 287(4):455-63. PubMed ID: 11798367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden uncontrollable somnolence and medication use in Parkinson disease.
    Avorn J; Schneeweiss S; Sudarsky LR; Benner J; Kiyota Y; Levin R; Glynn RJ
    Arch Neurol; 2005 Aug; 62(8):1242-8. PubMed ID: 16087765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
    Ondo WG; Perkins T; Swick T; Hull KL; Jimenez JE; Garris TS; Pardi D
    Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive daytime sleepiness and sleep episodes in Japanese patients with Parkinson's disease.
    Suzuki K; Miyamoto T; Miyamoto M; Okuma Y; Hattori N; Kamei S; Yoshii F; Utsumi H; Iwasaki Y; Iijima M; Hirata K
    J Neurol Sci; 2008 Aug; 271(1-2):47-52. PubMed ID: 18436241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep attacks in Parkinson's disease: a clinical and polysomnographic study.
    Pacchetti C; Martignoni E; Terzaghi M; Zangaglia R; Mancini F; Nappi G; Manni R
    Neurol Sci; 2003 Oct; 24(3):195-6. PubMed ID: 14598084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
    Grosset K; Needleman F; Macphee G; Grosset D
    Mov Disord; 2004 Nov; 19(11):1370-4. PubMed ID: 15389984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?
    Gjerstad MD; Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2006 Sep; 67(5):853-8. PubMed ID: 16966550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple latency test in a patient with episodes of sleep induced by pergolide].
    Jiménez-Jiménez FJ; Velasco I; de Toledo M; Sayed Y; Zurdo J; Ortí-Pareja M
    Rev Neurol; 2002 Jun 16-30; 34(12):1140-1. PubMed ID: 12134281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?
    Chaudhuri KR; Pal S; Brefel-Courbon C
    Drug Saf; 2002; 25(7):473-83. PubMed ID: 12093305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.